• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Mirati - oncology?





























Bms puts the ass kissing yes man in charge. Clearly they don’t want to keep research why have Jamie report to the lackey? He’s the only one that knows how to lead. Five bucks says most people peace out in Jan
 












































What’s the deal going to be with Mirati for retention? Anyone know? About to be in a similar situation with BMS and was curious if anyone could share.

90% + will be let go by the end of Q1. BMS staff will self preserve, so unless your role is uniquely part of a disease area portfolio they don't already have, your likely to be toast too!
 








Similar threads

Replies
0
Views
484
  • New replies moderating enabled
Replies
983
Views
232K
Replies
32
Views
18K